英文课件激素在溃疡性结肠炎的应用ppt_第1页
英文课件激素在溃疡性结肠炎的应用ppt_第2页
英文课件激素在溃疡性结肠炎的应用ppt_第3页
英文课件激素在溃疡性结肠炎的应用ppt_第4页
英文课件激素在溃疡性结肠炎的应用ppt_第5页
已阅读5页,还剩35页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、激素在溃疡性结肠炎的应用此ppt下载后可自行编辑英文课件The Clinical Application of Corticosteroids in Ulcerative ColitisTwo partsThe introduction of Ulcerative colitisThe clinical application of Corticosteroids in Ulcerative colitisUlcerative colitis Definition:Chronic non-specific colitisInflammation of the mucosa and submuc

2、osa of the large intestine Features:diarrhea with feces containing mucus, pus and blood, abdominal pain and tenesmus; and recurrence is commonMostly seen in 20-50 years of age, and in EuropeLess common in ChinaInfection Environmental factorsGenetic susceptibleImmune & inflammatory systemEtiology and

3、 pathogenesisLocation: rectum and sigmoid colon, then descending, transverse or pan-colon, even terminal ileumMucosa diffused inflammation with edema, congestion and local bleedings.PathologyInfiltration of lymphocytes, plasma cells, eosinophilic cells and neutrophilic cells in mucosaCryptic abscess

4、 and superficial ulcersInflammatory polyps or pseudopolyps;UCUCCryptic abscess in UCClinical Manifestations Symptoms: diarrhea abdominal pain, others : tenesmus, anorexia, nausea and vomiting Signs: tenderness in the left hypogastrium and rebound tendernessManifestations of digestive systemSystemic

5、manifestations fever,tachycardia,Anemia, malnutrition, volume depletion, disturbance in acid-basebalance and hypoalbuminemia in advanced patientsExtra-intestinal manifestationserythema nodosum, arthritis, ankylosing spondylitis, iritis,episcleritis, conjunctivitis, ulcers of oral mucosa, chronic act

6、ive hepatitis and so on.erythema nodosumA.course classificationinitial typechronic relapse typechronic permanent type acute and fulminant typeClinical classificationUC B.Extent classification (1) mild type (2) moderate type (3)severe typeClassificationUC C.range classificationProctitis or proctosigm

7、oiditis:40-50%Left-sided or intermediate colitis :30-40%Pancolitis:20% D.period classificationActive phaseAlleviative phaseClassificationUCUCendoscopic examinationDiseased mucosa: hyperemic and edematous, blood vessels not clear-cut, mucosa erosions and multiple shallow ulcers; rough, fragile, bleed

8、ing easily granular, pus; pseudopolyps seen Mucosa irregularity, saw-tooth like, loss of haustrations, shortening of colon and pseudopolyps formationContraindicated in fulminant typeUCBarium enematypical symptoms+one of endoscopic appearances and biopsy (or one of x-ray barium enema signs)+eliminati

9、on of other alike disease Notice:1.symptoms are not typical,while endoscopic appearances are typical-diagnosis 2.symptoms are typical, while endoscopic appearances are not typical-suspectDiagnosisTreatmentGeneral treatmentDrug treatmentSulfasalazineCorticosteroidsImmune inhibitorFirst choiceSevere p

10、atientsSurgical therapyIndications: abscess formation, canceration, perforation, fistula, mega-colon and refractory colitis, failure of medical therapy etcSecond partThe clinical application of Corticosteroids in Ulcerative colitisFinding CORTISONE IN ULCERATIVE COLITIS FINAL REPORT ON A THERAPEUTIC

11、 TRIALBRITISH MEDICAL JOURNAL On OCTOBER 29 1955S. C. TRUELOVE, M.D., M.R.C.P. AND L. J. WITTS, M.D., F.R.C.P.Conclusion the patients receiving cortisone enjoyed a clear-cut advantage over the patients on a dummy preparation. About two out of every five patients on cortisone therapy were in clinical

12、 remission at the end of six weeks treatment, compared with less than one out of every six patients receiving the inert therapy.Among the patients treated with cortisone those in their first attack have fared somewhat better than those in relapse.How to decide the dose of CorticosteroidsThe American

13、 Journal of GASTROENTEROLOGY Ulcerative Colitis Practice Guidelines in Adults by American College of Gastroenterology Practic Parameters CommitteeUlcerative Colitis Practice Guidelines in AdultsOral prednisone shows a dose response effect between 20 and 60 mg per day , with 60 mg per day modestly mo

14、re effective than 40 mg per day but at the expense of greater side-effects .Ulcerative Colitis Practice Guidelines in AdultsNo randomized trials have studied Corticosteroids taper schedules; most recommendations have advised 40 60 mg per day until significant clinical improvement occurs and then a d

15、ose taper of 5 10 mg weekly until a daily dose of 20 mg is reached. At this point tapering generally proceeds at 2.5 mg per week. The therapeutic plan is determined by the Patients condition and preferencessevere and fulminant typeFor patients who suffer from severe and fulminant type of UC :intrave

16、nous injection Corticosteroids is First choice , recommend dosage hydrocortisone 300mg or meprednisone 60d and moderate type with largely lesion For mild and moderate patient, First choice oral Sulfasalazine ,while it is not effective,recommend oral prednisone 2060 mg/dmild and moderate type w

17、ith Distal lesion Corticosteroids topical therapiesEffect of topical administration of budesonide and tranditional corticosteroids on active distal ulcerative colitis or proctitisShang hai Jiao tong University School of MedicineResearch fromConclusionThe effects of budesonide and traditional cortico

18、steroids on active distal Ulcerative colitis or Proctitis are similar.However, budesonide maybe Preferable to traditional corticosteroids ,since its inhibitory effect on Plasma cortisol level is lower than traditional corticosteroids.adverse effectsSuch as cushingoid features, emotional and psychiatric disturbances, infections, glaucoma.Complicationsinclude gastroduodenal mucosal injury, impaired wound healing, and metabolic bone disease.steroid-dependencyAlthough sho

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论